GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Ending Cash Position

LSL Pharma Group (TSXV:LSL) Ending Cash Position : C$0.29 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Ending Cash Position?

LSL Pharma Group's Ending Cash Position for the quarter that ended in Jun. 2024 was C$0.29 Mil.

LSL Pharma Group's quarterly Ending Cash Position declined from Dec. 2023 (C$0.01 Mil) to Mar. 2024 (C$-0.03 Mil) but then increased from Mar. 2024 (C$-0.03 Mil) to Jun. 2024 (C$0.29 Mil).

LSL Pharma Group's annual Ending Cash Position declined from Dec. 2021 (C$0.74 Mil) to Dec. 2022 (C$0.00 Mil) but then increased from Dec. 2022 (C$0.00 Mil) to Dec. 2023 (C$0.01 Mil).

LSL Pharma Group Ending Cash Position Historical Data

The historical data trend for LSL Pharma Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Ending Cash Position Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
Ending Cash Position
0.46 0.74 - 0.01

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 -0.03 0.01 -0.03 0.29

LSL Pharma Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LSL Pharma Group's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=-8.9511731360403E-16+0.0080000000000009
=0.01

LSL Pharma Group's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=-0.033+0.322
=0.29

LSL Pharma Group Ending Cash Position Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Ending Cash Position
Comparable Companies
XCNQ:ACRG.A.U TSX:AVNT XCNQ:MMEN XCNQ:CXXI TSX:AVCN XCNQ:TIUM.U TSXV:CANB XCNQ:GDNS TSXV:PCLO TSX:LABS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5
Website
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines